The macrolactam antibiotic vicenistatin, produced in Streptomyces halstedii HC34, is biosynthesized by the polyketide pathway, using a unique 3-methylaspartate-derived molecule as starter unit. The vinI gene in the vicenistatin biosynthetic gene cluster encoding glutamate mutase, which rearranges glutamate to 3-methylaspartate, was disrupted. The vinI disruption completely abolished the production of vicenistatin, while the disruptant recovered the production of vicenistatin when 3-methylaspartate was added to the culture. These results indicate that vinI is essential for the 3-methylaspartate formation in the vicenistatin biosynthesis. Furthermore, the mutant accumulated new vicenistatin derivatives (desmethylvicenistatins), which lacked a methyl group in the starter unit. The desmethylvicenistatins were shown by feeding experiments to be derived from aspartate instead of 3-methylaspartate as the starter unit. These results indicate that the vicenistatin polyketide synthase can accept alternative starter units toward the production of novel polyketides.
glutamate to (2S,3S)-3-methylaspartate in the mesaconate pathway for glutamate fermentation in various species of Clostridia [5] .
More recently, the vicenistatin biosynthetic (vin) gene cluster was cloned, sequenced, and analyzed [6] . Homology search analysis showed that VinH and VinI encoded in the vin cluster were homologous to the S and E subunits of glutamate mutase, respectively. Thus, it was reasonably explained on the genetic level that glutamate mutase would be involved in the 3-methylaspartate formation in the biosynthesis of vicenistatin. In this paper, we describe the functional confirmation by gene disruption of the vinI gene encoding a putative glutamate mutase.
The vinI gene was disrupted by insertional inactivation. A 5.6 kbp SalI fragment around the vinI region was subcloned into E. coli-Streptomyces shuttle vector pWHM3 (containing the thiostrepton resistance gene) [7] , and the apramycin resistant gene cassette, aac3(IV) [8] , was inserted between two SphI sites in the vinI coding region. The resulting plasmid pWHM-dGM was introduced into protoplasts of S. halstedii. For homologous recombination, the appropriate transformant was sporulated on R5 agar plates for 20 days. The resulting spores were separated into single clones, and the colonies, which showed a phenotype of thiostrepton-sensitive and apramycin-resistant, were picked up. The expected vinI gene disruption was confirmed by PCR using primers designed for the two sides of the vinI gene. The size of the PCR product from the disruptant genome was 1.5 kbp larger (size of the apramycin resistant gene cassette) than that of the wild type as shown in Fig. 3 .
The mutant and wild type of S. halstedii were cultured, and the products was extracted with acetone and ethyl acetate as previously described [1] . The resulting extracts were analyzed by HPLC with a Senshu Pak ODS column (PEGASIL ODS 4.6 mm, 250 mm) at 40°C with a solvent of MeOH : water : TFA (70 : 30 : 0.1) at a flow rate of was restored (Fig. 4B ). These results clearly prove that vinI is involved in the 3-methylaspartate formation in vicenistatin biosynthesis. This is the first evidence of involvement of the vin genes in the vicenistatin biosynthesis on the genetic level. Interestingly, instead of vicenistatin a new peak with a retention time of 7 minutes appeared in the culture of the vinI mutant (Fig. 4A ). This peak was purified by silica gel chromatography (CHCl 3 : MeOHϭ10 : 1) and by preparative HPLC (same conditions as described above), and analyzed by MS, C-NMR spectra. Since the mixture (2 and 3) was inseparable under several conditions, the structures were determined without further separation. The 1 H and 13 C-NMR data of 2 and 3 are summarized in Table 1 . Signals for the aglycone parts of the two compounds were almost identical to those of vicenistatin, although the signal for H-23 (0.94 ppm) of the starter methyl group of vicenistatin was absent. Thus, the desmethylvicenilactam skeleton was deduced for the new compounds. A significant difference between these two compounds was found in the sugar moiety. One of the sugar moieties was determined to be vicenisamine by comparison with the signals of vicenistatin. The 1 H-spin network and coupling constants (Jϭ10 Hz) between 3Ј-H and 4Ј-H indicated that the other was a C-3 epimer of vicenisamine, 3-epivicenisamine. Thus, 2 and 3 were determined to be 18-desmethylvicenistatin and 3Ј-epi-18-desmethylvicenistatin, respectively. The production of 3Ј-epi-18-desmethylvicenistatin was unexpected, because 3Ј-epivicenisaminide has not been isolated in the wild type of S. halstedii. Although it is not clear at the moment the reason why the vinI mutant produces 3'-epivicenisaminide, manipulation of the vinI gene may affect sugar biosynthesis.
Since comparable amounts of desmethylvicenistatins 2 and 3 were not found in the culture of the wild-type and the vinI mutant supplied with 3-methylaspartate, 2 and 3 might be produced only in the absence of 3-methylaspartate. It was speculated that aspartate, instead of 3-methylaspartate, was converted to b-alanine, which became a starter unit for the desmethylvicenilactams. [9] and balanine [10] were prepared by published methods. The results show that the deuterium of labeled aspartate was incorporated into H-18 of desmethylvicenistatins, but no incorporation was observed in the case of b -alanine (Fig. 5) . The similar phenomenon was observed in previous feeding experiments, in which 3-methylaspartate was incorporated into vicenistatin, but its decarboxylated product aminomethylpropionate was not. As we proposed previously [4] , it is hypothesized that a more complicated pathway between 3-methylaspartate/aspartate and aminomethylpropionate/b -alanine could exist beyond just a decarboxylation prior to the PKS reaction. In summary, the glutamate mutase vinI mutant of S. halstedii was successfully constructed and it was clearly proven that vinI is essential for 3-methylaspartate formation in vicenistatin biosynthesis. In addition, desmethylvicenistatins were isolated from the vinI mutant. These results show that the vicenistatin biosynthetic enzymes, including the PKS, are able to accept a starter unit besides 3-methylaspartate. The precise functional analysis of the biosynthetic enzymes will provide opportunities to produce new vicenistatin derivatives. 
